Patented Market Application Examples
Ultra-lightweight, flexible and disposable skin patches are combined with Gentag wireless sensors to simplify diagnostics, diabetes monitoring, drug compliance monitoring, and other market applications. Gentag can custom-design and license its wearable patch technology for a wide array of consumer or medical applications.
Gentag has identified 25 major markets for its patented wireless patches. Some of these markets have already been licensed; market examples are given below.
Obtaining sensor information is as easy as applying a Gentag smart skin patch, then reading it with your smartphone. It really is that simple.
Fever
A less invasive, more effective way to take temperature. Gentag’s low-cost, disposable fever patches can be used to provide temperature readings without disturbing the patient. We are working with global industry leaders to advance the business of medical-grade thermometry and fever onset detection for epidemics (e.g. Covid-19).
Contact Gentag for details.
Pain-Free Diabetes Monitoring
The patented Gentag diabetes patch platform ushers in a new era of accurate, low-cost and pain-free glucose measurements using ordinary cell phones. NFC allows for the creation of tiny glucose sensors that are wireless and can be placed anywhere, including under the skin. An added battery and the use of Bluetooth allows for CGM monitoring, as described in the Gentag patents.
The wireless diabetes patch platform is currently available for licensing in 28 European countries under Patent EP1709750 and in the U.S. under Patents US7969307 and US8077042 (closed loop insulin delivery system).
Cosmetics and Skin Health
Wearable sensors are ideal for monitoring environmental conditions such as UV exposure, and physiological conditions such as sweat, skin moisture, and biomarkers. These sensors can then send information directly to your smartphone that would alert you if, for instance, you needed to reapply sunscreen, change brands, or if there is a potential health issue you should be concerned with. Cosmetics monitoring patches can be produced in high volumes at very low cost.
Contact Gentag for details.
Cardiac Patches
Gentag owns early issued US and European patent claims on wireless cardiac skin patches compatible with cell phones. By using Artificial Intelligence (AI), cardiac patches can be customized to detect signature events linked to highly specific cardiac medical problems. The cardiac patch IP is complemented by Gentag’s IP covering rapid tests for specific cardiac biomarkers; it represents an ideal package in conjunction with cardiac drugs for home self-monitoring.
The cardiac IP is currently available for licensing.
Contact Gentag for details.